Axcella Health ~ David Epstein
Axcella Health (NASDAQ: AXLA) $.179b David Epstein COB consulting agreement
$$$ Base retainer $300,000 & annual option to purchase 65,000 shares stock / Ms. Catherine Sohn joins Board x- GlaxoSmithKline plc SVP BM- Jazz Pharmaceuticals plc Rubius Therapeutics, Landec Corp succeeds Christopher Viehbacher resigns from Board